ATE392901T1 - Mucuna pruriens und extrakte daraus zur behandlung von neurologischen erkrankungen - Google Patents

Mucuna pruriens und extrakte daraus zur behandlung von neurologischen erkrankungen

Info

Publication number
ATE392901T1
ATE392901T1 AT03809721T AT03809721T ATE392901T1 AT E392901 T1 ATE392901 T1 AT E392901T1 AT 03809721 T AT03809721 T AT 03809721T AT 03809721 T AT03809721 T AT 03809721T AT E392901 T1 ATE392901 T1 AT E392901T1
Authority
AT
Austria
Prior art keywords
mucuna pruriens
preparation
pharmaceutical composition
neurological diseases
substances
Prior art date
Application number
AT03809721T
Other languages
English (en)
Inventor
Der Giessen Robert H M Van
Waren Olanow
Andrew Lees
Hildebert Wagner
Original Assignee
Phytrix Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phytrix Ag filed Critical Phytrix Ag
Application granted granted Critical
Publication of ATE392901T1 publication Critical patent/ATE392901T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Electrotherapy Devices (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
AT03809721T 2002-10-30 2003-10-02 Mucuna pruriens und extrakte daraus zur behandlung von neurologischen erkrankungen ATE392901T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02024475 2002-10-30

Publications (1)

Publication Number Publication Date
ATE392901T1 true ATE392901T1 (de) 2008-05-15

Family

ID=32187158

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03809721T ATE392901T1 (de) 2002-10-30 2003-10-02 Mucuna pruriens und extrakte daraus zur behandlung von neurologischen erkrankungen

Country Status (8)

Country Link
US (1) US7470441B2 (de)
EP (1) EP1567177B1 (de)
JP (1) JP2006507288A (de)
AT (1) ATE392901T1 (de)
AU (1) AU2003276041A1 (de)
CA (1) CA2504201A1 (de)
DE (1) DE60320579D1 (de)
WO (1) WO2004039385A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8142800B1 (en) * 2001-12-18 2012-03-27 Tamea Rae Sisco Oral high potency clinical anti-craving treatment and method of use
CA2556169C (en) * 2004-01-29 2011-11-22 Andrew Lees Use of amino-oxy functional groups in the preparation of vaccines
US20050202111A1 (en) * 2004-03-04 2005-09-15 Manyam Bala V. Anti-Parkinson's disease pharmaceutical and method of use
CA2758948A1 (en) * 2009-04-17 2010-10-21 Somalabs, Inc. Method for the induction of a reward response by modulation of dopaminergic systems in the central nervous system
WO2011017101A2 (en) 2009-07-27 2011-02-10 Fina Biosolutions, Llc Method for producing protein-carbohydrate vaccines reduced in free carbohydrate
BR122022002139B1 (pt) 2009-12-17 2022-08-23 Fina Biosolutions, Llc Processo de conjugação de carboidratos na preparação de vacinas conjugadas e suas respectivas vacinas
ES2743156T3 (es) 2010-04-23 2020-02-18 Serum Institute Of India Pvt Ltd Método simple para eliminación simultánea de múltiples impurezas a partir de sobrenadantes de cultivo a niveles ultrabajos
KR101063935B1 (ko) * 2010-07-16 2011-09-14 한국전기연구원 자기정렬법을 이용한 탄화규소 전계효과 트랜지스터 소자의 제조방법
US10588890B2 (en) * 2017-05-30 2020-03-17 Biommunity, Inc. Compositions and methods to regulate hormonal cascades in stress disorders
WO2019060661A1 (en) * 2017-09-22 2019-03-28 Iowa State University Research Foundation, Inc. PROBIOTIC COMPOSITIONS FOR THE PRODUCTION OF DOPAMINE
WO2020076485A2 (en) * 2018-09-21 2020-04-16 Iowa State University Research Foundation, Inc. Genetic elements in enterococcus spp. to produce dopamine
CN109096131B (zh) * 2018-09-28 2021-01-15 那坡康正天然植物提取有限责任公司 一种利用猫豆制备左旋多巴的工艺
CN109081787B (zh) * 2018-09-28 2021-01-15 那坡康正天然植物提取有限责任公司 一种从黎豆中提取左旋多巴的工艺
WO2022192275A1 (en) * 2021-03-08 2022-09-15 University Of Connecticut Assisted loading of hydrophobic molecules into liposomes
EP4384194A4 (de) 2021-10-08 2025-07-16 Univ Iowa State Res Found Inc Verwendung von dopamin produzierenden produkten zur erhöhung der impfstoffwirksamkeit

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941835A (en) * 1970-03-19 1976-03-02 Bio-Derivatives Corporation Recovery of L-Dopa from R-dopa containing materials
US3666802A (en) * 1970-05-04 1972-05-30 Millmaster Onyx Corp Recovery of 3-(3,4-dihydroxyphenyl)-l-alanine from beans with water
US6106839A (en) * 1999-05-29 2000-08-22 Pruthi; Som C. Ayurvedic composition for the treatment of disorders of the nervous system including Parkinson's disease
WO2002069921A1 (en) * 2001-03-07 2002-09-12 Unilever Plc Hair colouring compositions

Also Published As

Publication number Publication date
WO2004039385A3 (en) 2004-07-01
JP2006507288A (ja) 2006-03-02
WO2004039385A2 (en) 2004-05-13
US7470441B2 (en) 2008-12-30
EP1567177B1 (de) 2008-04-23
AU2003276041A1 (en) 2004-05-25
EP1567177A2 (de) 2005-08-31
US20060165822A1 (en) 2006-07-27
AU2003276041A8 (en) 2004-05-25
CA2504201A1 (en) 2004-05-13
DE60320579D1 (de) 2008-06-05

Similar Documents

Publication Publication Date Title
DE60320579D1 (de) Mucuna pruriens und extrakte daraus zur behandlung von neurologischen erkrankungen
WO2001009118A3 (en) Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement
LUC00011I2 (de)
TW200501983A (en) Uses of anti-insulin-like growth factor I receptor antibodies
DE60321929D1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
AU2003301190A1 (en) Administration of capsaicinoids
ZA200503656B (en) Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline
EP2460522A3 (de) Verfahren und Zusammensetzungen, die immunmodulatorische Verbindungen verwenden, zur Behandlung und Pflege bei Krebs- und anderen Erkrankungen
TW200800976A (en) New compounds for the treatment of neurological, psychiatric or pain disorders
WO2005046593A3 (en) Methods and compositions using thalidomide for the treatment and management of cancers and other diseases.
WO2004093881A3 (en) Use of dipyridamole or mopidamole for treatment and prevention of thrombo-embolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of thrombin receptors
TW200505909A (en) Arylvinylazacycloalkane compounds and methods of preparation and use thereof
AU2001266289A1 (en) 2-arachidonylglycerol (2-ag) - an inhibitor of tumor necrosis factor -alfa and neuroprotector of brain in closed head injury
BRPI0410651A (pt) composto, composição farmacêutica, e, métodos para tratar ou prevenir cáncer, degeneração macular do tipo úmida ou artrite reumatóide, vascularização aberrante, nìveis de cobre em excesso, obesidade e doença neurodegenerativa em um paciente
ATE409039T1 (de) Kombinationstherapie gegen krebserkrankungen mit azd2171 und zd1839
BR0317772A (pt) Método de tratamento de um distúrbio de comportamento, uso de um composto, e, agente terapêutico para um distúrbio de comportamento
ATE482217T1 (de) Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen
WO2003066806A3 (en) Therapeutic use of aziridino compounds
TW200500073A (en) Pharmaceutical composition comprising an indolopyrrolocarbazole derivative and use thereof
NZ608560A (en) Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions
DE60308127D1 (de) Pharmazeutische Zusammentsetzung zur medizinischen Behandlung von gutartiger prostathyperplasie, dessen Vorbereitungsmethode und dessen therapeutische Verwendung
BRPI0416019A (pt) uso de siramesina ou de um seu sal farmaceuticamente aceitável, composição farmacêutica, kit, e, método para o tratamento de cáncer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties